低NIHSS评分急性前循环卒中:取栓与药物治疗比较
该研究汇总3个前瞻性国际队列中前循环大血管闭塞且基线NIHSS≤6、发病12小时内的患者,经倾向性评分匹配后比较血管内治疗与药物治疗。结果显示两组90天极佳功能结局比例无显著差异,但血管内治疗组24小时神经功能恶化风险更高。
要点
- 低NIHSS评分前循环大血管闭塞患者中,取栓与药物治疗90天极佳结局比例相似。
- 取栓组24小时神经功能恶化风险较药物治疗组高22.3%(95%CI 3.0%-41.6%)。
- 该研究为Class III证据,支持低NIHSS评分患者两种策略90天结局相似。
核心结论
- 低NIHSS评分前循环大血管闭塞患者中,取栓与药物治疗90天极佳功能结局比例相似。
- 取栓与24小时神经功能恶化风险增加相关。
研究设计与样本
- 汇总3个前瞻性国际队列中前循环大血管闭塞患者,纳入发病12小时内且基线NIHSS≤6者。
- 共236例符合纳入标准,其中取栓组139例、药物治疗组97例,采用倾向性评分匹配调整非随机治疗分配。
主要发现
- 匹配前取栓组较药物治疗组更年轻(65 vs 72岁;p < 0.001),近端闭塞更多(p < 0.001),同期静脉溶栓比例更低(57.7% vs 71.2%;p = 0.04)。
- 倾向性评分匹配后两组临床结局无显著差异。
- 取栓组90天极佳结局率较药物治疗组高8.6%(95%CI -8.8%至26.1%)。
- 取栓组24小时神经功能恶化风险较药物治疗组高22.3%(95%CI 3.0%-41.6%)。
关键数值与推荐
- 主要结局为90天改良Rankin量表(mRS)评分0-1分。
- 次要结局包括24小时神经功能恶化(NIHSS变化≥2分)、90天mRS 0-2分及90天全因死亡率。
- 该研究提供Class III证据:急性前循环缺血性卒中伴大血管闭塞且NIHSS<6的患者,取栓与药物治疗90天结局相似。
临床怎么用
- 对低NIHSS评分前循环大血管闭塞患者,取栓与药物治疗90天极佳功能结局比例相似。
- 取栓需权衡24小时神经功能恶化风险增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To undertake an effectiveness and safety analysis of EVT in patients with LVO and NIH Stroke Scale (NIHSS) score ≤6 using datasets of multicenter and multinational nature. METHODS: We pooled patients with anterior circulation occlusion from 3 prospective international cohorts. Patients were eligible if presentation occurred within 12 hours from last known well and baseline NIHSS ≤6. Primary outcome was modified Rankin Scale (mRS) score 0-1 at 90 days. Secondary outcomes included neurologic deterioration at 24 hours (change in NIHSS of ≥2 points), mRS 0-2 at 90 days, and 90-day all-cause mortality. We used propensity score matching to adjust for nonrandomized treatment allocation. RESULTS: Among 236 patients who fit inclusion criteria, 139 received EVT and 97 received medical management. Compared to medical management, the EVT group was younger (65 vs 72 years; p < 0.001), had more proximal occlusions (p < 0.001), and less frequently received concurrent IV thrombolysis (57.7% vs 71.2%; p = 0.04). After propensity score matching, clinical outcomes between the 2 groups were not significantly different. EVT patients had an 8.6% (95% confidence interval [CI] -8.8% to 26.1%) higher rate of excellent 90-day outcome, despite a 22.3% (95% CI, 3.0%-41.6%) higher risk of neurologic deterioration at 24 hours. CONCLUSIONS: EVT for LVO in patients with low NIHSS score was associated with increased risk of neurologic deterioration at 24 hours. However, both EVT and medical management resulted in similar proportions of excellent clinical outcomes at 90 days. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that for patients with acute anterior circulation ischemic strokes and LVO with NIHSS < 6, EVT and medical management result in similar outcomes at 90 days.
引用
- Volny O, Zerna C, Tomek A, et al. Thrombectomy vs medical management in low NIHSS acute anterior circulation stroke. Neurology. 2020. PMID: 32989100. doi:10.1212/WNL.0000000000010955
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。